Search

Your search keyword '"Scott, David W."' showing total 2,577 results

Search Constraints

Start Over You searched for: Author "Scott, David W." Remove constraint Author: "Scott, David W."
2,577 results on '"Scott, David W."'

Search Results

2. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration

3. MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma

4. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment

7. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)

8. Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma

9. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis

10. Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

11. Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas

12. Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

16. Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

17. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns

18. Nonparametric Density Estimation for High-Dimensional Data - Algorithms and Applications

19. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population

21. Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

22. Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial

23. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

25. A single-cell multiomics analysis of IRF4 in mediating treatment resistance in ibrutinib-treated chronic lymphocytic leukemia (CLL).

26. The Hybrid Bootstrap: A Drop-in Replacement for Dropout

28. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

30. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

31. The House that Madigan Built: The Record Run of Illinois' Velvet Hammer

32. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk

34. Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP

35. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma

36. Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma

37. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma

38. Abstract P11: ARID1A mutations shape memory B-cell dynamics and confer sensitivity to SWI/SNF remodeling complex inhibition in lymphoma

41. Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

42. CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

43. Unbalanced MYCbreak-apart FISH patterns indicate the presence of a MYCrearrangement in HGBCL-DH-BCL2

49. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Catalog

Books, media, physical & digital resources